Institut Paoli Calmettes Lymphoma Database
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations
- Status
- COMPLETED
- Phase
- NA
A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
- Status
- COMPLETED
- Phase
- PHASE2
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Signal Detection in Monoclonal and New Agents in Lymphoma
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Cohort of Lymphoma Patients in Malawi
- Status
- RECRUITING
- Phase
- N/A
Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
- Status
- COMPLETED
- Phase
- N/A
PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE4
Low-dose Radiotherapy for Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab in Pediatric and Adolescent Patients
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)
- Status
- WITHDRAWN
- Phase
- PHASE2
PERCIST Criteria for Response Evaluation With Solid Tumors
- Status
- UNKNOWN
- Phase
- N/A
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Early Life Exposures in Agriculture
- Status
- COMPLETED
- Phase
- N/A